6 Related NICE guidance | Denosumab for the prevention of osteoporotic fractures in postmenopausal women | Guidance | NICE

Download guidance (PDF)

6 Related NICE guidance

Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (amended).NICE technology appraisal guidance 160 (2008; amended 2010).
Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (amended).NICE technology appraisal guidance 161 (2008; amended 2010).